ArticleJournal of Cancer2018
Trends in Treatment for Prostate Cancer in China: Preliminary Patterns of Care Study in a Single Institution.
Article in Journal of Cancer, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed, 17 citations in OpenAlex.
- Radium-223 in Asian patients with castration-resistant prostate cancer with symptomatic bone metastases: A single-arm phase 3 study.Asia-Pacific journal of clinical oncology · 2021Trial
- Lack of real-world evidence on active surveillance in Chinese patients with prostate cancer: insights from a 10-year cohort and a physician survey.BMC urology · 2026Observational
- Preoperative predictors about lymph node metastasis and biochemical recurrence in high-risk prostate cancer patients: a clinic pathological retrospective study.BMC urology · 2025Article
- Prostate cancer in China: epidemiological trends, genomic insights, and future directions for optimized management.Journal of the National Cancer Center · 2025Review
- Cost-effectiveness analysis of prostate-specific antigen screening in China: a middle-income population-based microsimulation study.The Lancet regional health. Western Pacific · 2025Article
- Diagnostic value comparison of the combination of prostate-specific membrane antigen-body PET/MR and the prostate health index with each alone in early diagnosis of prostate cancer.Asian journal of urology · 2024Article
- Article
- PDZRN4 suppresses tumorigenesis and androgen therapy-resistance in prostate cancer.Journal of Cancer · 2022Article
- Single-site multiport vs. conventional multiport robot-assisted radical prostatectomy: A propensity score matching comparative study.Frontiers in surgery · 2022Article
- Use of miR‑145 and testicular nuclear receptor 4 inhibition to reduce chemoresistance to docetaxel in prostate cancer.Oncology reports · 2021Article
- Association of long-chain non-coding RNA GAS5 gene polymorphisms with prostate cancer risk and prognosis in Chinese Han population.Medicine · 2020Article
- Cost-Effectiveness Analysis of Prostate Health Index in Decision Making for Initial Prostate Biopsy.Frontiers in oncology · 2020Article
- Long non-coding RNA NORAD induces cell proliferation and migration in prostate cancer.The Journal of international medical research · 2019Article
- Current Treatment for Low-Risk Prostate Cancer in China: A National Network Survey.Journal of Cancer · 2019Article
- Prostate Health Index (Asian journal of andrologyObservational
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.